RS
BCYC

R Squared’s Bicycle Therapeutics BCYC Stock Holding History

R Squared’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.7K Buy
+21,057
New +$120K 0.05% 371
2025
Q1 		– Sell
-180
Closed -$2.52K – 433
2024
Q4 		$2.52K Buy
+180
New +$3.86K ﹤0.01% 1438

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

R Squared's BCYC Position: Q1 2026 in Review

R Squared opened a new position in Bicycle Therapeutics (BCYC) in Q1 2026: 21,057 shares worth $97.7K. The stake represents 0.05% of the portfolio and ranks #371 among its holdings. This is a return to the name: R Squared previously reported a position in BCYC as recently as Q4 2024.

R Squared first reported a position in BCYC in Q4 2024 and has held it in 2 quarters since. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • R Squared held 21,057 shares of Bicycle Therapeutics worth $97.7K as of Q1 2026.
  • Bicycle Therapeutics was a new R Squared position in Q1 2026.
  • Bicycle Therapeutics made up 0.05% of R Squared's portfolio in Q1 2026, its #371 holding.
  • R Squared first reported a position in Bicycle Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.